|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.93 USD | -7.32% |
|
-7.32% | -62.70% |
| 06-18 | Fat, not muscle: Drugmakers in race for next weight-loss breakthrough | RE |
| 06-18 | Fat, not muscle: Drugmakers in race for next weight-loss breakthrough | RE |
| Capitalization | 1.54B 1.33B 1.24B 1.15B 2.12B 133B 2.38B 15.05B 5.67B 62.16B 5.79B 5.67B 229B | P/E ratio 2025 * |
-1.99x | P/E ratio 2026 * | -2.35x |
|---|---|---|---|---|---|
| Enterprise value | 1.03B 890M 830M 769M 1.42B 88.7B 1.59B 10.06B 3.79B 41.53B 3.87B 3.79B 153B | EV / Sales 2025 * |
148x | EV / Sales 2026 * | 9.53x |
| Free-Float |
84.47% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Biohaven Ltd.
More news
| 1 day | +8.87% | ||
| 1 week | -7.32% | ||
| Current month | -1.28% | ||
| 1 month | -4.33% | ||
| 3 months | -31.62% | ||
| 6 months | -62.94% | ||
| Current year | -62.70% |
| 1 week | 13.04 |  | 15.37 |
| 1 month | 13.04 | | 15.37 |
| Current year | 13.04 | | 44.28 |
| 1 year | 13.04 | | 55.7 |
| 3 years | 5.54 | | 62.21 |
| 5 years | 5.54 | | 62.21 |
| 10 years | 5.54 | | 62.21 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vladimir Coric
CEO | Chief Executive Officer | 54 | 01/05/2022 |
Matthew Buten
DFI | Director of Finance/CFO | 63 | 27/09/2022 |
Jon Blaskovich
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Vladimir Coric
CHM | Chairman | 54 | 01/05/2022 |
| Director/Board Member | 60 | 31/12/2019 | |
Gregory Bailey
BRD | Director/Board Member | 69 | 27/09/2022 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0.01% | 9 M€ | +5.66% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.32% | -7.32% | -61.61% | - | 1.54B | ||
| +0.19% | +1.03% | +10.09% | +1.28% | 50.03B | ||
| +4.01% | +14.59% | +88.98% | +63.90% | 34.39B | ||
| +2.04% | +1.01% | +2.34% | +9.85% | 28.64B | ||
| +2.91% | -1.38% | -29.11% | -25.48% | 28.24B | ||
| +1.09% | +1.16% | +26.11% | -21.83% | 12.59B | ||
| +1.97% | -3.41% | -56.01% | -30.43% | 11.67B | ||
| +1.03% | +0.40% | +27.88% | +107.66% | 10.73B | ||
| +1.13% | +1.76% | +52.20% | - | 10.5B | ||
| -0.12% | -0.64% | +10.40% | -3.12% | 10.45B | ||
| Average | +2.19% | +1.35% | +7.12% | +12.73% | 19.88B | |
| Weighted average by Cap. | +1.51% | +2.39% | +16.83% | +12.41% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 6.97M 6.01M 5.61M 5.2M 9.58M 599M 10.75M 67.96M 25.59M 281M 26.13M 25.59M 1.03B | 120M 103M 96.25M 89.18M 164M 10.29B 184M 1.17B 439M 4.82B 449M 439M 17.76B |
| Net income | -806M -695M -649M -601M -1.11B -69.34B -1.24B -7.86B -2.96B -32.47B -3.02B -2.96B -120B | -768M -663M -618M -573M -1.06B -66.08B -1.18B -7.49B -2.82B -30.94B -2.88B -2.82B -114B |
| Net Debt | -512M -442M -412M -382M -704M -44.04B -790M -4.99B -1.88B -20.62B -1.92B -1.88B -76.02B | -403M -347M -324M -300M -554M -34.65B -621M -3.93B -1.48B -16.22B -1.51B -1.48B -59.8B |
More financial data
* Estimated data
Employees
256
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/25 | 15.11 $ | +13.10% | 2,466,821 |
| 16/07/25 | 13.36 $ | +0.75% | 1,255,891 |
| 15/07/25 | 13.26 $ | -6.55% | 1,623,286 |
| 14/07/25 | 14.19 $ | +1.87% | 1,345,029 |
| 11/07/25 | 13.93 $ | -7.32% | 1,701,726 |
End-of-day quote Nyse, July 10, 2025
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
15.11USD
Average target price
54.21USD
Spread / Average Target
+258.77%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BHVN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition